Clinical Trial Update: An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1b open-label trial evaluating acalabrutinib with and without dexamethasone in adults with multiple myeloma; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Acalabrutinib (acalabrutinib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Acerta Pharma BV | Conditions: Multiple Myeloma (MM) | Phase 1 | Status: COMPLETED | Results posted: 2020-05-13